- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PUR003
Total 106 results
-
Pulmatrix Inc.Quintiles, Inc.; Retroscreen Virology Ltd.Completed
-
Pulmatrix Inc.McMaster University; St. Joseph's Healthcare Hamilton / Firestone Institute...Completed
-
Purinomia Biotech, Inc.RecruitingAdvanced Solid TumorsUnited States
-
Pulmatrix Inc.Quotient ClinicalCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Biotheus Inc.RecruitingAdvanced Solid TumorsChina
-
Sinotau Pharmaceutical GroupCompletedCoronary Artery Disease (CAD)China
-
Prothena Biosciences LimitedCompleted
-
Prothena Biosciences LimitedCompleted
-
Sinotau Pharmaceutical GroupCompleted
-
Apros Therapeutics, IncCompletedAdvanced Colorectal CarcinomaUnited States
-
Realm Therapeutics, Inc.CompletedAllergic ConjunctivitisUnited States
-
Ultragenyx Pharmaceutical IncCompleted
-
Pearl Therapeutics, Inc.Completed
-
Palobiofarma SLNovartis; H. Lee Moffitt Cancer Center and Research InstituteCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Kyowa Kirin Co., Ltd.CompletedMultiple Myeloma and Malignant LymphomaJapan
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal CancerSpain, Italy, Singapore, Canada, Israel, Korea, Republic of, Netherlands, Australia
-
Pulmatrix Inc.Completed
-
Pearl Therapeutics, Inc.CompletedHealthy VolunteersAustralia
-
Novartis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungBelgium, Germany, United States, Canada, France, Italy, Japan, Korea, Republic of, Spain
-
Pearl Therapeutics, Inc.Completed
-
Yonsei UniversityWithdrawn
-
Joyce FoxUltragenyx Pharmaceutical IncNo longer availableMucopolysaccharidosis Type 7United States
-
Millennium Pharmaceuticals, Inc.CompletedDigestive System DiseaseUnited States
-
Ultragenyx Pharmaceutical IncAvailableSly Syndrome | Mucopolysaccharidosis VII | MPS VII
-
Ultragenyx Pharmaceutical IncCompletedMucopolysaccharidosis | Sly Syndrome | MPS VII | MPS 7United States
-
Pearl Therapeutics, Inc.Terminated
-
Novartis PharmaceuticalsTerminatedSolid Tumors and LymphomasUnited States, Australia, Netherlands, Canada, Germany, Switzerland, Japan, Spain
-
Novartis PharmaceuticalsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Renal Cancer | Hepatocellular CancerTaiwan, Germany, Italy, Austria, Switzerland, Hong Kong, Japan, Canada, United States
-
Novartis PharmaceuticalsCompletedSolid Tumors | LymphomasSpain, Canada, Singapore, Israel, Japan, United States
-
Mayo ClinicUniversity of MinnesotaNot yet recruiting
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Triple Negative Breast Cancer, NSCLC - AdenocarcinomaUnited States, France, Taiwan, Canada, Italy, Singapore, Belgium, Spain, Israel
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Cancer | NSCLC | Other Solid TumorsItaly, Spain, Netherlands, France, Korea, Republic of, Switzerland, Germany, Japan, United States, Canada
-
Novartis PharmaceuticalsCompletedSoft Tissue Sarcoma | Small Cell Lung Cancer | Gastric Adenocarcinoma | Diffuse Large B Cell Lymphoma | Esophageal Adenocarcinoma | Ovarian Adenocarcinoma | Castration Resistant Prostate Adenocarcinoma | Advanced Well-differentiated Neuroendocrine TumorsUnited States
-
Novartis PharmaceuticalsCompletedMultiple MyelomaUnited States, Italy, Spain, Germany
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedWell-differentiated Non-functional NET of Thoracic Origin | Well-differentiated Non-functional NET of Gastrointestinal Origin | Well-differentiated Non-functional NET of Pancreatic Origin | Poorly-differentiated Gastroenteropancreatic Neuroendocrine CarcinomaUnited States, Italy, Spain, Japan, Belgium, Netherlands, Germany, France, Canada, Austria, United Kingdom, Australia
-
Asan Medical CenterUnknownCancer | Lung Cancer Metastatic | ImmunotherapyKorea, Republic of
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
Novartis PharmaceuticalsCompletedNasopharyngeal CarcinomaUnited States, China, Taiwan, Singapore, Hong Kong, Thailand, France
-
Novartis PharmaceuticalsTerminatedSolid TumorsUnited States, Germany, Spain, Belgium, Korea, Republic of, Japan, Italy
-
Assistance Publique - Hôpitaux de ParisSuspendedGastric Adenocarcinoma | Oesophageal AdenocarcinomaFrance
-
Novartis PharmaceuticalsCompletedHepatocellular Carcinoma (HCC) | Solid MalignanciesUnited States, Germany, Taiwan, Spain, Singapore, France, Japan, Korea, Republic of, Hong Kong, China, Italy
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsUnited States, Canada, France, Taiwan, Belgium, Spain, Singapore, Italy, Australia, Hong Kong, Germany, Japan
-
Yonsei UniversityActive, not recruitingHistologically Confirmed Unresectable or Metastatic Squamous Cell Carcinoma of the Esophagus Who Failed on Standard TreatmentKorea, Republic of
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal CancerUnited States, Taiwan, Spain, Germany, Japan, Hong Kong
-
Seoul National University HospitalUnknownGastric CancerKorea, Republic of
-
National Taiwan University HospitalNovartisActive, not recruiting
-
Ultragenyx Pharmaceutical IncCompletedMucopolysaccharidosis | Sly Syndrome | Mucopolysaccharidosis VII | MPS VIIUnited States, Brazil, Mexico, Portugal
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Solid Tumors | Triple Negative Breast Cancer | Chordoma and Alveolar Soft Part SarcomaUnited States, Taiwan, Spain, Canada, Singapore, Italy, Japan, Israel, France
-
Pearl Therapeutics, Inc.Completed